Efficacy and Safety of Systemic and Locoregional Cisplatin Chronotherapy in Rats with Ovarian Carcinoma.
Galina KireevaEkaterina A GubarevaMikhail A MaidinVladislav OsetnikStepan KruglovAndrey V PanchenkoAnastasia DorofeevaMargarita TyndykElena FedorosVladimir AnisimovPublished in: OncoTargets and therapy (2021)
In a rat model, ovarian tumor growth disrupted daily variations in intestinal epithelium proliferation and caused genotoxic stress in tumor-free tissues. HIPEC with cisplatin at ZT0 had a better efficacy/toxicity profile than HIPEC with cisplatin at ZT12 and IV administration at both time points.